A longitudinal study involving paired single-cell transcriptomic profiling has identified critical cellular mechanisms driving the transformation of chronic-phase chronic myeloid leukemia (CML-CP) into B-lymphoblastic blast crisis (BLBC). The research, published in Molecular Medicine, delineates the evolutionary trajectory of the disease, highlighting substantial remodeling of the hematopoietic landscape during progression. Blast transformation is associated with the selective expansion of lymphoid-primed BCR::ABL1-positive progenitor populations, a process characterized by specific molecular programs that distinguish the progression to BLBC.
To investigate the cellular states and lineage trajectories involved in this transition, researchers conducted single-cell RNA sequencing (scRNA-seq) on five bone marrow samples. This cohort included two longitudinally paired CML-CP and BLBC sample sets from individual patients, alongside one additional BLBC sample. The team performed integrative analyses by incorporating publicly available scRNA-seq datasets from two patients with de novo Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia (Ph+ B-ALL) to determine the unique cellular characteristics of BLBC. Further validation of key findings was conducted using an external microarray dataset, an in-house bulk RNA-seq dataset, quantitative real-time PCR (qRT‒PCR), and flow cytometry.
The findings indicate that the hematopoietic landscape undergoes significant reorganization during disease progression. In the chronic phase, the samples displayed heterogeneous hematopoietic outputs with both erythroid- and myeloid-biased lineages, which were associated with distinct transcriptional programs. In contrast, the BLBC samples exhibited a marked shift toward relatively quiescent, stem cell-like cellular states.
A central finding of the research is the activation of a distinct lymphoid-associated transcriptional program during blast transformation. This molecular signature is characterized by the increased expression of CD24, DNTT, and RAG1.
Comparative analyses of the scRNA-seq data revealed that CML-BLBC exhibits a transcriptional landscape distinct from that of de novo Ph+ B-ALL. Among the genes identified as consistently upregulated in CML-BLBC, CD24 emerged as a key factor specifically enriched within ProB and PreB populations. This progressive upregulation of CD24 during the evolution of the disease was independently confirmed across all validation platforms, including microarray analysis and clinical flow cytometry.
The study also evaluated the clinical implications of these findings, particularly concerning treatment efficacy. Elevated CD24 expression was found to be associated with an inferior response to imatinib in untreated CML patients.
The researchers conclude that their paired longitudinal single-cell atlas provides a clearer understanding of the evolutionary trajectory from CML-CP to BLBC. The selective expansion of lymphoid-primed BCR::ABL1-positive progenitors, driven by the coordinated upregulation of CD24, DNTT, and RAG1, appears to be a key molecular event in this process.
Subject of Research: Molecular mechanisms of blast transformation in chronic myeloid leukemia
Article Title: Paired longitudinal single-cell profiling reveals clonal evolution and lymphoid lineage restriction during progression from chronic-phase CML to B-lymphoblastic blast crisis
Article References: Yan, S., Huang, D., Wang, X., Xie, F., & Zhang, X. (2026). Paired longitudinal single-cell profiling reveals clonal evolution and lymphoid lineage restriction during progression from chronic-phase CML to B-lymphoblastic blast crisis. Molecular Medicine. https://doi.org/10.1186/s10020-026-01681-4
Image Credits: AI Generated
DOI: 10.1186/s10020-026-01681-4
Keywords: Chronic Myeloid Leukemia, CML, Blast Crisis, Single-cell RNA sequencing, Transcriptomics, Clonal evolution, CD24, Hematopoiesis, B-lymphoblastic blast crisis, Lineage restriction, BCR::ABL1, Imatinib resistance, Leukemia research, Molecular medicine, Cell states
News Source: Gavin Prescott. (November 18, 2026). Single-Cell Profiling Reveals Clonal Evolution in CML-to-BLBC Disease Progression. Scienmag.



